Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

High-dose thiotepa and twice-daily treatments increase the risk of permanent hair loss in children receiving craniospinal irradiation.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Tislelizumab can cause cutaneous lupus erythematosus.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

TriCell CD34+ cell-containing PRP therapy improves hair thickness and density in alopecia patients without side effects.

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Selective chemical epilation effectively treats tinea capitis without harmful side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Assessing oral health before chemotherapy is crucial to reduce harmful side effects.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.